Ireland’s Neuromod gets €30M to increase reach of tinnitus treatment tech

Anyone who has ever experienced phantom ringing in their ears knows that it is a nuisance to say the least. Those who have tinnitus – hearing continuous ringing, buzzing, humming or even roaring sounds – often experience anxiety and depression as a result.  The condition affects approximately 15% of the global adult population. However, treatment has remained elusive, with those afflicted left to find their own ad hoc mitigation solutions.  Neuromod, a medtech startup from Ireland, is looking to change that. The company has just received €30 million in funding to further commercialise its tinnitus treatment device, Lenire.  A different…

This story continues at The Next Web

from LatestTechyTalks